-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Terns Pharmaceuticals, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2020 to Q2 2024.
- Terns Pharmaceuticals, Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was $2.86M, a 14.2% decline year-over-year.
- Terns Pharmaceuticals, Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was $12.6M, a 60.8% increase year-over-year.
- Terns Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2023 was $12.6M, a 516% increase from 2022.
- Terns Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2022 was $2.04M, a 872% increase from 2021.
- Terns Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2021 was $210K.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)